Malaria remains a major public health concern worldwide. Malaria is endemic in Mozambique, with seasonal fluctuations throughout the country. Although the number of malaria cases in Mozambique have dropped by 11% from 2020 to 2021, there are still hotspots in the country with persistent high incidence and low insecticide-treated bed net usage. The aim of this study is to evaluate the factors associated with the use of long-lasting insecticidal nets by pregnant women and women with children under 5 years old in two hotspot districts in the Gaza province, Mozambique. A descriptive, qualitative cross-sectional study was conducted between June 15th and 21st 2022. An in-depth interview process was conducted with pregnant women and mothers with children under five years old, exploring their beliefs, experiences, and perception of messages conveyed by health professionals when long-lasting insecticidal nets were being supplied. A total of 48 women participated (24 pregnant women and 24 women with children under 5 years). Most participants recognized the protective effects of long-lasting insecticidal nets in preventing malaria, and understood that women and children were high risk groups. The nets were reported to cause side effects and difficulty breathing by 100% of pregnant women, while 54.2% of mothers with children under 5 reported no side effects. The majority of women in both groups reported that their health professionals did not educate them about how to use or handle the nets properly. Only 16.7% of mothers with children under 5 received correct handling instructions. Providing clear, culturally sensitive, and practical information on the correct use of LLINs, as well as regular monitoring of their proper use, would be a great step forward for Mozambique’s national malaria program.
Background/Objectives: Mental health challenges may compromise long-term HIV treatment outcomes, yet evidence linking psychosocial and mental health indicators with viral suppression remains limited in Mozambique. We examined the association between psychosocial and mental health indicators and viral non-suppression among adults receiving antiretroviral therapy (ART) in Gaza Province. Methods: We conducted a cross-sectional analytical study among 343 adults receiving ART at seven public health facilities in Xai-Xai District, Mozambique, in 2023–2024. The primary exposure was endorsement of at least one of three psychosocial and mental health indicators: social isolation, sadness, or use of medication for mental health problems. The primary outcome was viral non-suppression. Associations were estimated using Firth penalized logistic regression because of the small number of non-suppression events. Results: Overall, 41/343 participants (12.0%) reported at least one psychosocial or mental health indicator. Viral load results were available for 338 participants, of whom 19 (5.6%) had viral non-suppression. Viral non-suppression was more frequent among participants reporting at least one indicator than among those reporting none (12.2% vs. 4.7%). Reporting at least one indicator was associated with higher odds of viral non-suppression in unadjusted analysis (OR 2.95, 95% CI 1.04–8.34) and after adjustment for age and sex (aOR 2.97, 95% CI 1.05–8.38). After additional adjustment for ART duration, the association was attenuated and statistically uncertain (aOR 2.12, 95% CI 0.71–6.37). Social isolation showed the largest estimated crude odds ratio (OR 8.17, 95% CI 1.70–39.29), although estimates were imprecise. Conclusions: In the primary model adjusting for age, sex, and ART duration, the association was attenuated and imprecise (aOR 2.12, 95% CI 0.71–6.37). The findings are hypothesis-generating and should be interpreted in light of non-validated exposure measurement, substantial missing exposure information, and few non-suppression events.
Background Malaria Mass Drug Administration (MDA) is recommended to reduce malaria in low transmission settings, with a target coverage of ≥80%. This study assesses the feasibility of a programmatic MDA (pMDA) pilot implementation in southern Mozambique. Methods The National Malaria Control Programme implemented pMDA in Chidenguele (Gaza Province), where the estimated population is 59,271. Two rounds of door-to-door distribution (using satellite maps with previously enumerated households (Reveal® platform)) with fixed points were conducted between December 2022 and February 2023. Household coverage was estimated with both district census data and satellite number of expected households. All eligible individuals ≥6 months received a full therapeutic 3-day-course of dihydroartemisinin-piperaquine. Individual data collection was conducted during round 1 (R1), which was changed to aggregated data at the household level in round 2 (R2). Community engagement and human resources were also strengthened between the two rounds. The target number of households to be reached by team/day was 25/30 in R1 and 15 in R2. Results When using census data, household coverage (households reached over targeted) increased from 59.4% (8799/14818) in R1 to 94.3% (13972/14818) in R2, while with the satellite estimates, it increased from 62.5% (8799/14075) to 99.3% (13972/14075). Population programmatic coverage (individuals treated over total population) increased from 40.9% (24237/59271) to 69.8% (41347/59271). Treatment rate among present individuals (operational coverage) decreased from 91.3% (24237/26541) to 85.1% (41347/48588). Conclusion Collecting aggregated data, decreasing the household target per day per team and using fixed-points at the end as a recovery strategy helped improve operational performance. However, reaching an 80% programmatic coverage is challenging even with high rates of household visitation and operational coverage, mainly due to absences and exclusions. Funding: This project is funded by the EDCTP2 Programme.